In summary, our study identified several independent risk factors for MF-ICC, including single lesion, tumor size ≥5cm, hypo-echogenicity, presence of tumor necrosis, absence of rim APHE, lower CEA level, elevated CA19-9 and CA-125 level. This evidence concerns the gene CEACAM5 and intrahepatic cholangiocarcinoma.